Uranium Royalty

TOR:URC · CA91702V1013

Oil, Gas & Consumable FuelsSmall

360

Medium confidence — indicative

Value40

Profit price—

Cash yield39

Owner Earnings Yield76

Dividend Yield1

Sales & asset price27

Price/Sales27

EV / Gross Profit3

Price/Book52

Quality56

Returns on capital40

Return on Capital35

Return on Equity45

Profit margins28

EBIT Margin42

Gross Profitability14

Cash backing88

Cash Conversion94

Accruals82

Growth71

Sales growth98

Profit growth90

Profit Growth97

Long-Term EPS Growth82

Reinvestment14

Price momentum69

Safety—

Debt load100

Debt serviceability92

Liquidity96

Sentiment57

Analyst ratings78

Expectations trend66

Opinion Changes50

Price Target Upside81

Market mood100

Value Creation13/20creating some value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Uranium Royalty clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryCanada

IndustryOil, Gas & Consumable Fuels

SizeSmall

TypePublic Company

ExchangeTSX

Founded2017

Employees9

Websiteuraniumroyalty.com

ISINCA91702V1013

Last UpdateApr 2, 2026

Indices

NASDAQ (USA)

Themes

Conventional NuclearMining

Description

Uranium Royalty Corp. (URC) operates as a pure-play uranium royalty company. The company focuses on gaining exposure to uranium prices by making strategic investments in uranium interests, including royalties, streams, debt and equity investments in…

Analysis

Middle-of-the-road

Uranium Royalty Corp. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is solid; the safety picture is uncertain. The company scores 13/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250

100

2026

All-time high

100

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Uranium Royalty with its peers

B2Gold

TOR:BTO

CountryCanada

IndustryMetals & Mining

SizeLarge

Full Stock Analysis →

Loar Holdings

NYQ:LOAR

CountryUSA

IndustryAerospace & Defense

SizeMedium

Full Stock Analysis →

Embecta

NSQ:EMBC

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeMedium

Full Stock Analysis →

PhenixFIN

NMQ:PFX

CountryUSA

IndustryCapital Markets

SizeSmall

Full Stock Analysis →

Kestra Medical Technologies

NSQ:KMTS

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeSmall

Full Stock Analysis →

Amneal Pharmaceuticals

NSQ:AMRX

CountryUSA

IndustryPharmaceuticals

SizeLarge

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →